These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 16012767

  • 1. Prognostic predictors in breast cancer patients with postoperative 5-fluorouracil-based chemotherapy.
    Hakamada Y, Tsuchida A, Arima M, Kubouchi T, Tokita H, Ota D, Kaise H, Aoki T, Kusama M, Aoki T.
    Int J Mol Med; 2005 Aug; 16(2):309-14. PubMed ID: 16012767
    [Abstract] [Full Text] [Related]

  • 2. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Ciaparrone M, Quirino M, Schinzari G, Zannoni G, Corsi DC, Vecchio FM, Cassano A, La Torre G, Barone C.
    Oncology; 2006 Aug; 70(5):366-77. PubMed ID: 17179731
    [Abstract] [Full Text] [Related]

  • 3. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
    Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.
    J Clin Oncol; 2006 Sep 01; 24(25):4062-8. PubMed ID: 16943523
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacogenetic studies on the prediction of efficacy and toxicity of fluoropyrimidine-based adjuvant therapy in colorectal cancer].
    Kralovánszky J, Adleff V, Hitre E, Pap E, Réti A, Komlósi V, Budai B.
    Magy Onkol; 2007 Sep 01; 51(2):113-25. PubMed ID: 17660867
    [Abstract] [Full Text] [Related]

  • 5. Establishment of enzyme-linked immunosorbent assays for thymidylate synthase and dihydropyriminide dehydrogenase in cancer tissues.
    Kurebayashi J, Yamamoto Y, Udagawa K, Okubo S, Fukushima M, Sonoo H.
    Oncol Rep; 2004 May 01; 11(5):973-9. PubMed ID: 15069534
    [Abstract] [Full Text] [Related]

  • 6. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.
    Foekens JA, Romain S, Look MP, Martin PM, Klijn JG.
    Cancer Res; 2001 Feb 15; 61(4):1421-5. PubMed ID: 11245445
    [Abstract] [Full Text] [Related]

  • 7. [Clinical significance of intratumoral TS levels and DPD activity in breast cancer].
    Miyashita M, Yoshimura H, Hatta K, Tachibana S, Kubota M, Takahashi H, Yamazaki Y, Maeda K, Okita Y, Takao S.
    Gan To Kagaku Ryoho; 2009 Mar 15; 36(3):407-11. PubMed ID: 19295264
    [Abstract] [Full Text] [Related]

  • 8. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4116-24. PubMed ID: 14519634
    [Abstract] [Full Text] [Related]

  • 9. [Estimation of level of enzyme induction of thymidine phosphorylase, dihydropyrimidine dehydrogenase, and thymidylate synthase in primary and recurrent breast cancer].
    Morimoto K, Koh M.
    Gan To Kagaku Ryoho; 2004 Apr 15; 31(4):529-38. PubMed ID: 15114696
    [Abstract] [Full Text] [Related]

  • 10. [Significance of thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) activity in breast cancer tissue].
    Hakamada Y, Arima M, Misaka T, Yasuda D, Matsunaga T, Kusama M, Aoki T, Sekiguchi N, Koyanagi Y.
    Gan To Kagaku Ryoho; 2000 Jul 15; 27(7):1003-10. PubMed ID: 10925685
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
    Fukuda H, Takiguchi N, Koda K, Oda K, Seike K, Miyazaki M.
    Cancer Invest; 2006 Jul 15; 24(3):235-41. PubMed ID: 16809149
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of 5-fluorouracil metabolic enzyme genes in Dukes' stage B and C colorectal cancer patients treated with oral 5-fluorouracil-based adjuvant chemotherapy.
    Yamada H, Iinuma H, Watanabe T.
    Oncol Rep; 2008 Mar 15; 19(3):729-35. PubMed ID: 18288408
    [Abstract] [Full Text] [Related]

  • 14. Intratumoral expression of thymidylate synthase and dihydropyrimidine dehydrogenase in non-small cell lung cancer patients treated with 5-FU-based chemotherapy.
    Huang CL, Yokomise H, Kobayashi S, Fukushima M, Hitomi S, Wada H.
    Int J Oncol; 2000 Jul 15; 17(1):47-54. PubMed ID: 10853017
    [Abstract] [Full Text] [Related]

  • 15. [Results of prophylactic hepatic arterial chemotherapy for liver metastases of Dukes C colorectal cancer--correlation with tumoral expression of dihydropyrimidine dehydrogenase, thymidylate synthase, p53, or orotate phosphoribosyl transferase].
    Ishida H, Yamada H, Shirakawa K, Nakada H, Ohsawa T, Takeuchi I, Okada N, Yokoyama M, Inokuma S, Suzuki T, Odaka A, Hoshino T, Murata N, Hashimoto D, Itoyama S, Mori T, Matsumoto Y, Miura T.
    Gan To Kagaku Ryoho; 2003 Oct 15; 30(11):1621-6. PubMed ID: 14619479
    [Abstract] [Full Text] [Related]

  • 16. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 15; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 17. Thymidylate synthetase and dihydropyrimidine dehydrogenase levels in gastric cancer.
    Ishikawa Y, Kubota T, Otani Y, Watanabe M, Teramoto T, Kumai K, Takechi T, Okabe H, Fukushima M, Kitajima M.
    Anticancer Res; 1999 Jul 15; 19(6C):5635-40. PubMed ID: 10697632
    [Abstract] [Full Text] [Related]

  • 18. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
    Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM, GEICAM 9906 Study Investigators.
    J Natl Cancer Inst; 2008 Jun 04; 100(11):805-14. PubMed ID: 18505968
    [Abstract] [Full Text] [Related]

  • 19. [Significance of tissue PyNPase, TS, and DPD activities in breast cancer].
    Kosaka A, Mori K, Shikata A.
    Gan To Kagaku Ryoho; 2002 Aug 04; 29(8):1395-401. PubMed ID: 12214467
    [Abstract] [Full Text] [Related]

  • 20. Dihydropyrimidine dehydrogenase and thymidylate synthase activities in hepatocellular carcinomas and in diseased livers.
    Baba H, Teramoto K, Kawamura T, Mori A, Imamura M, Arii S.
    Cancer Chemother Pharmacol; 2003 Dec 04; 52(6):469-76. PubMed ID: 13680162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.